Technical Analysis for CHRS - Coherus BioSciences, Inc.

Grade Last Price % Change Price Change
grade A 19.0 1.33% 0.25
CHRS closed up 1.33 percent on Friday, August 17, 2018, on 56 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical CHRS trend table...

Date Alert Name Type % Chg
Aug 17 Bollinger Band Squeeze Range Contraction 0.00%
Aug 17 NR7 Range Contraction 0.00%
Aug 16 Spinning Top Other 1.33%
Aug 16 Bollinger Band Squeeze Range Contraction 1.33%
Aug 15 Bollinger Band Squeeze Range Contraction 3.26%
Aug 14 New 52 Week Closing High Bullish -2.06%
Aug 14 180 Bullish Setup Bullish Swing Setup -2.06%
Aug 14 Bollinger Band Squeeze Range Contraction -2.06%
Aug 14 BB Squeeze Started Range Contraction -2.06%
Aug 14 BB Squeeze + Upper Band Touch Range Contraction -2.06%

Older signals for CHRS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Coherus Biosciences, Inc., a late-stage clinical biologics platform company, focuses on developing and commercializing biosimilar products worldwide. Its clinical stage pipeline consists of CHS-0214, an etanercept biosimilar candidate, which is in two Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis; CHS-1420, an adalimumab biosimilar candidate that has completed a Phase I study to treat psoriasis or rheumatoid arthritis; and CHS-1701, a pegfilgrastim biosimilar candidate, which has completed a Phase I study for the treatment of breast cancer patients exhibiting chemotherapy-induced neutropenia. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus Biosciences, Inc. in April 2012. Coherus Biosciences, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Is CHRS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 19.6
52 Week Low 8.05
Average Volume 633,215
200-Day Moving Average 12.7901
50-Day Moving Average 16.8155
20-Day Moving Average 18.575
10-Day Moving Average 18.71
Average True Range 0.8785
ADX 19.0
+DI 18.7955
-DI 14.389
Chandelier Exit (Long, 3 ATRs ) 16.9645
Chandelier Exit (Short, 3 ATRs ) 19.8905
Upper Bollinger Band 19.4273
Lower Bollinger Band 17.7227
Percent B (%b) 0.75
BandWidth 9.176851
MACD Line 0.6069
MACD Signal Line 0.6717
MACD Histogram -0.0648
Fundamentals Value
Market Cap 975.57 Million
Num Shares 51.3 Million
EPS -2.60
Price-to-Earnings (P/E) Ratio -7.31
Price-to-Sales 3.37
Price-to-Book 17.33
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.90
Resistance 3 (R3) 19.83 19.47 19.75
Resistance 2 (R2) 19.47 19.24 19.50 19.70
Resistance 1 (R1) 19.23 19.10 19.35 19.30 19.65
Pivot Point 18.87 18.87 18.93 18.90 18.87
Support 1 (S1) 18.63 18.64 18.75 18.70 18.35
Support 2 (S2) 18.27 18.50 18.30 18.30
Support 3 (S3) 18.03 18.27 18.25
Support 4 (S4) 18.10